Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series A
MedTech
PHASE Scientific raises $34M for urine-based diagnostic platform
The Hong Kong-based company—founded in 2015 as a UCLA spinout—said it has already conducted over 8 million lab tests worldwide.
Conor Hale
May 21, 2025 11:15am
Fierce Biotech Fundraising Tracker: CellCentric, Stylus & more
May 21, 2025 6:30am
Third Rock-backed Merida unveils with $121M for autoimmune plans
Apr 8, 2025 11:03am
Frazier arms Callio with $187M series A to fly Hummingbird's ADC
Mar 3, 2025 9:00am
Boston biotech banks $90M for next-gen bispecifics
Feb 14, 2025 10:10am
Newleos unveils with $93M and 4 ex-Roche programs
Feb 13, 2025 12:00am
